Company intelligence
Aligos Therapeutics
Improving patient outcomes through best-in-class therapies for liver and viral diseases
Biotechnology
South San Francisco, US
97 employees
Founded 2018
1 public signals
About Aligos Therapeutics
Aligos is a clinical stage biotechnology company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for high unmet medical needs such as chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronaviruses.
Verified activity
Signals from Aligos Therapeutics
1 published signal